For the Inventor, By the Inventor

Enter assignee name

Pleasanton, CA, United States of America

Neotract, Inc.

USPTO Granted Patents = 68

% Expired Patents = 16.2

EPO Patents = 11

Trademarks = 4

Forward Citations = 6,316

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Joseph Catanese, Iii (64 out of 85 patents)

Theodore Charles Lamson (56 out of 94 patents)

Joshua Makower (38 out of 280 patents)

4. Floria Cheng (29 out of 37 patents)

5. Michael Collinson (29 out of 46 patents)

6. Claude A Vidal (29 out of 58 patents)

7. Russell J Redmond (29 out of 82 patents)

8. Daniel Merrick (26 out of 30 patents)

9. Matthew McLean (25 out of 47 patents)

10. Jacqueline Nerney Welch (24 out of 27 patents)

11. Amik Nagpurkar (19 out of 19 patents)

12. Amrish Jayprakash Walke (17 out of 72 patents)

13. Ling-Kang Tong (16 out of 22 patents)

14. Brian Y Tachibana (14 out of 24 patents)

15. Michael Gearhart (13 out of 18 patents)

Core Competencies:

Anchor Delivery System

Benign Prostatic Hyperplasia

Tissue Manipulation

Latching Anchor Device

Median Lobe Destruction

Suture Anchoring Devices

Multi-Actuating Trigger

Coiled Anchor Device

Flexible Anchor Delivery

Integrated Handle Assembly

Continuous Indentation Apparatus

Retracting Tissue Systems

68 patents: Sort by Forward Citations

1. 11129608 - Anchor delivery system (2021-09-28),

2. 11090036 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions (2021-08-17),

3. 10945719 - Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures (2021-03-16),

4. 10925587 - Anchor delivery system (2021-02-23),

5. 10912637 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions (2021-02-09),

6. 10702261 - System with reloadable handle for delivering an anchor (2020-07-07),

7. 10575844 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions (2020-03-03),

8. 10492792 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions (2019-12-03),

9. 10426509 - Median lobe destruction apparatus and method (2019-10-01),

10. 10349932 - Anchor delivery system (2019-07-16),

11. 10299780 - Apparatus and method for manipulating or retracting tissue and anatomical structure (2019-05-28),

12. 10292801 - System for delivering anchors for treating incontinence (2019-05-21),

13. 10265061 - Latching anchor device (2019-04-23),

14. 10201343 - System for delivering an anchor (2019-02-12),

15. 10195014 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions (2019-02-05),

Company Overview

Neotract, Inc., based in Pleasanton, California, specializes in innovative medical devices aimed at addressing urological conditions, particularly benign prostatic hyperplasia (BPH). The company focuses on developing advanced technologies such as anchor delivery systems and latching anchor devices, which facilitate tissue manipulation and median lobe destruction. Their solutions aim to enhance patient outcomes through minimally invasive procedures, reflecting a commitment to improving the quality of life for individuals affected by prostate-related issues.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

68 Patents

#12 in Pleasanton, CA

#1,254 in California

#5,372 in US

#10,888 in the World

Pleasanton, CA, United States of America

Neotract, Inc.

Forward Citations = 6,316

45 inventors:

Joseph Catanese, Iii (64 out of 85 patents)

Theodore Charles Lamson (56 out of 94 patents)

Joshua Makower (38 out of 280 patents)

4. Floria Cheng (29 out of 37 patents)

5. Michael Collinson (29 out of 46 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neotract, Inc.. Retrieved from https://idiyas.com/company/neotract

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…